Clinical Trial Update: Ivermectina Colombia (IVERCOL) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for ivermectin (IVERCOL) in COVID-19 pneumonia spanning Phase 2 and Phase 3, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• IVERMECTIN (Ivermectin)

Snippet

Sponsor: Ayudas Diagnosticas Sura S.A.S | Conditions: COVID-19 Pneumonia | Phase 2, Phase 3 | Status: UNKNOWN